Literature DB >> 3025363

Purification and amino terminal sequencing of human melanoma nerve growth factor receptor.

N Marano, B Dietzschold, J J Earley, G Schatteman, S Thompson, P Grob, A H Ross, M Bothwell, B F Atkinson, H Koprowski.   

Abstract

The nerve growth factor (NGF) receptor, solubilized with Triton X-100 detergent, has been purified from human melanoma cell line A875. Purification to near-homogeneity was achieved by chromatography on wheat germ agglutinin-agarose, followed by immunoaffinity chromatography on Sepharose columns coupled with anti-NGF receptor monoclonal antibody (MAb). The purified receptor, a 75,000-dalton protein, retains the capacity to bind NGF as well as anti-receptor MAbs. Final purification was achieved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The sequence of amino acid residues at the amino terminus has been determined. Possible sequence homology between the NGF receptor and several other proteins is discussed. Using the purified receptor as immunogen, new MAbs to the NGF receptor have been produced. The NGF receptor was visualized by immunoperoxidase staining in tissue sections of dorsal root ganglia from monkeys.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025363     DOI: 10.1111/j.1471-4159.1987.tb13151.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Nerve growth factor and neuronal cell death.

Authors:  J R Perez-Polo; P J Foreman; G R Jackson; D Shan; G Taglialatela; L W Thorpe; K Werrbach-Perez
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

Review 2.  Tropomyosin-receptor-kinases signaling in the nervous system.

Authors:  Bogdan Stoleru; Alisa Madalina Popescu; Daniela Elise Tache; Oana Maria Neamtu; Ghazaleh Emami; Ligia Gabriela Tataranu; Alice Sandra Buteica; Anica Dricu; Stefana Oana Purcaru
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.

Authors:  Xiao-Qing Yang; Yun-Fei Xu; Sen Guo; Yi Liu; Shang-Lei Ning; Xiao-Fei Lu; Hui Yang; Yu-Xin Chen
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Efficient processing and expression of human nerve growth factor receptors in Xenopus laevis oocytes: effects on maturation.

Authors:  A Sehgal; D A Wall; M V Chao
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

5.  Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733.

Authors:  A J Linnenbach; J Wojcierowski; S A Wu; J J Pyrc; A H Ross; B Dietzschold; D Speicher; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex.

Authors:  Mary-Louise Rogers; Sheree Bailey; Dusan Matusica; Ian Nicholson; Hakan Muyderman; Promila C Pagadala; Kenneth E Neet; Heddy Zola; Peter Macardle; Robert A Rush
Journal:  J Neuroimmunol       Date:  2010-06-14       Impact factor: 3.478

7.  Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain.

Authors:  C R Buck; H J Martinez; I B Black; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Modeled structure of the 75-kDa neurotrophin receptor.

Authors:  B S Chapman; I D Kuntz
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

9.  Circular dichroism and crosslinking studies of the interaction between four neurotrophins and the extracellular domain of the low-affinity neurotrophin receptor.

Authors:  D E Timm; A H Ross; K E Neet
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

10.  Basic fibroblast growth factor enhances nerve growth factor receptor gene promoter activity in human neuroblastoma cell line CHP100.

Authors:  M Taiji; K Taiji; K L Deyerle; M Bothwell
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.